Skip to content
Screener

Arcutis Biotherapeutics, Inc. ARQT Business Segments — Provision for income taxes

Similar metrics at other companies

Target logo
TGTReportable Segment — Provision for income taxes
$252M-27.2%
Adobe logo
ADBEReportable Segment — Provision for income taxes
$526M+28.3%
Samsara logo
IOTReportable Segment — Provision for income taxes
$4.42M+178%
Zoom Video Communications, Inc. logo
ZMReportable Segment — Provision for income taxes
$105.94M+73.2%
Biohaven logo
BHVNReportable Segment — Provision for income taxes
$272K-55.3%
DocuSign logo
DOCUReportable Segment — Provision for income taxes
$39.56M+2,223%

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M
CapEx$158.0K+103%
Free cash flow$12.5M

Valuation

See full
Market cap$3.32B+81.4%
Enterprise value$3.4B+82.1%
P/S7.2×+0.2×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other segment expenses(1)6,2955,50912,15612,694
Total operating expenses113,43296,115227,919186,490
Operating income (loss)16,429(14,611)7,340(39,140)
Interest income2,2792,0764,5544,613
Interest expense(3,406)(3,029)(7,774)(6,011)
Other income (expense), net(157)20(177)213
Provision for income taxes136342229621
Segment and consolidated net income (loss)$15,009$(15,886)$3,714$(40,946)

Item 1. Financial Statements (Unaudited)

FAQ

What is Arcutis Biotherapeutics, Inc.'s business segments — provision for income taxes?
Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — provision for income taxes of $136K in Q2 2026.
How has Arcutis Biotherapeutics, Inc.'s business segments — provision for income taxes changed year-over-year?
Arcutis Biotherapeutics, Inc.'s business segments — provision for income taxes decreased by 60.2% year-over-year, from $342K to $136K.
What does business segments — provision for income taxes mean?
This metric represents the total income tax expense recognized by the reportable segment for the period, calculated based on applicable tax laws and jurisdictional regulations. It reflects the tax burden associated with the segment's operational activities and profitability. Monitoring this figure helps investors understand the effective tax rate applied to the segment's earnings and potential future cash outflows for tax obligations.

Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — provision for income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude